| Opening Remark |
|
|
Kenji Yamamoto (International Medical center of Japan) |
| Preparation of quantum dots |
|
Yukio Yamaguchi (University of Tokyo, Graduate School of Engineering) |
| New approach of quantum dots |
|
Akihiko Kondo (Kobe University, Graduate school of Science and Technology) |
| New approach of quantum dots |
|
Tadafumi Adschiri, Takashi Naka, Satoshi Ohara, Mitsuo Umetsu
(Tohoku University, Institute of Multidisciplinary Research for Advanced Materials) |
| Synthesis of sililcon nanoparticles fot biomedical applications |
|
Richard Tilley (University of Wellington, New Zealand) |
| Quantum dots with silica shells |
|
Thomas Nann (Albert-Ludwig University Freiburg, Germany) |
| The safety of the colloidal quantum dots |
|
Toshihiro Ohta (Tokyo University of Pharmacy and Life Science) |
| Quantum dots-tagged medicine |
|
Noriyoshi Manabe (International Medical Center of Japan) |
| Immune cell tracing using quantum dots |
|
Akiyoshi Hoshino (International Medical Center of Japan |
| An application of quantum dots in ophthalmology |
|
Satoru Yamamoto (Yokohama Sakae Kyosai Hospital) |
| Estimation of the develpoment of the RPGN by the quantum dots |
|
Kazuo Suzuki (National Institute of Infectious Diseases) |
|
|
